Bay Street News, January 8th, 2024

NEW ALBANY, Ohio, Jan. 08, 2024 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) today provided a business update, […]

MONTRÉAL, 08 janv. 2024 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) a annoncé aujourd’hui la nomination de Rémi G. Lalonde […]

MONTREAL, Jan. 08, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) today announced the appointment of Remi G. Lalonde […]

Highlights Company has received final assays from Phase II of its two-phase 2023 soil-sampling program Phase II Program extends two […]

SYRACUSE, N.Y., Jan. 08, 2024 (GLOBE NEWSWIRE) — Carrols Restaurant Group, Inc. (“Carrols” or the “Company”) (Nasdaq: TAST), the largest […]

– Industry-leading PK Activator Franchise Has Demonstrated Clinical Efficacy in Four Hematological Diseases, Including New Positive Phase 3 Data in […]

– Initial Data from the Ongoing Phase 2 Trial in Combination with the Antibody-Drug Conjugate (ADC) Sacituzumab Govitecan (SG) Suggest […]

SAN MATEO, Calif. and SINGAPORE, Jan. 08, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (NASDAQ: ASLN) (“ASLAN” or the “Company”), announced […]

RESEARCH TRIANGLE PARK, N.C., Jan. 08, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company […]

STAMFORD, Conn., Jan. 08, 2024 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe […]